Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Rossi Michael A., Chief Financial Officer. Insider active across 2 companies, notably HARVARD BIOSCIENCE INC. In total, 7 reports have been published. History available since 11 June 2021. The latest transaction was disclosed on 29 December 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Michael A. Rossi is the Chief Financial Officer at Harvard Bioscience Inc. He oversees the financial operations of the company, including financial planning and risk management. His role is essential in ensuring the financial health and growth of the company.